Literature DB >> 19687773

Impact of fish oil-based lipid emulsion on serum triglyceride, bilirubin, and albumin levels in children with parenteral nutrition-associated liver disease.

Sang I Lee1, Clarissa Valim, Patrick Johnston, Hau D Le, Jonathan Meisel, Danielle A Arsenault, Kathleen M Gura, Mark Puder.   

Abstract

Parenteral nutrition is known to cause liver injury in babies. The aim of this study is to investigate the effects of different lipid emulsions on parenteral nutrition-associated cholestasis in infants. In addition, there may be a relationship between the lipid emulsion and triglyceride levels. Furthermore, triglyceride levels may correlate with direct bilirubin and albumin, as markers of liver impairment and nutritional status. Patients with parenteral nutrition-associated cholestasis who were treated with a fish oil-based lipid emulsion (n = 18) were prospectively followed for triglyceride, direct bilirubin, and albumin levels and compared with patients who were maintained on a soy-based lipid emulsion (n = 59). Triglyceride levels decreased in the fish oil cohort from a mean of 140 mg/dL at wk 0 to 40 mg/dL at wk 20 but remained unchanged at approximately 140 mg/dL in the soybean cohort. Triglyceride levels of patients treated with fish oil declined over time, while those receiving soybean oil did not. Also, changes in triglyceride levels over time were directly correlated with direct bilirubin and inversely related to albumin levels. These findings may indicate an added benefit of reduced triglyceride levels for patients treated with fish oil and this effect coincides with markers for improved liver function and nutritional status.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19687773      PMCID: PMC3377973          DOI: 10.1203/PDR.0b013e3181bbdf2b

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  21 in total

Review 1.  Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association.

Authors:  Penny M Kris-Etherton; William S Harris; Lawrence J Appel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-02-01       Impact factor: 8.311

Review 2.  Total parenteral nutrition-associated liver disease.

Authors:  Alan Buchman
Journal:  JPEN J Parenter Enteral Nutr       Date:  2002 Sep-Oct       Impact factor: 4.016

Review 3.  Cardiovascular effects of n-3 fatty acids.

Authors:  A Leaf; P C Weber
Journal:  N Engl J Med       Date:  1988-03-03       Impact factor: 91.245

4.  n-3 fatty acid-enriched eggs, lipids, and Western diet: time for change.

Authors:  A P Simopoulos
Journal:  Nutrition       Date:  1993 Nov-Dec       Impact factor: 4.008

5.  Total parenteral nutrition: a histopathologic analysis of the liver changes in 20 children.

Authors:  F G Mullick; C A Moran; K G Ishak
Journal:  Mod Pathol       Date:  1994-02       Impact factor: 7.842

6.  Total parenteral nutrition-associated intrahepatic cholestasis in infants: 25 years' experience.

Authors:  A Kubota; T Yonekura; M Hoki; H Oyanagi; H Kawahara; M Yagi; K Imura; Y Iiboshi; K Wasa; S Kamata; A Okada
Journal:  J Pediatr Surg       Date:  2000-07       Impact factor: 2.545

7.  Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease.

Authors:  Julia Araya; Ramón Rodrigo; Luis A Videla; Lilian Thielemann; Myriam Orellana; Paulina Pettinelli; Jaime Poniachik
Journal:  Clin Sci (Lond)       Date:  2004-06       Impact factor: 6.124

Review 8.  Abnormalities of liver function and hepatic damage associated with total parenteral nutrition.

Authors:  H R Freund
Journal:  Nutrition       Date:  1991 Jan-Feb       Impact factor: 4.008

9.  Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease.

Authors:  Kathleen M Gura; Sang Lee; Clarissa Valim; Jing Zhou; Sendia Kim; Biren P Modi; Danielle A Arsenault; Robbert A M Strijbosch; Suzanne Lopes; Christopher Duggan; Mark Puder
Journal:  Pediatrics       Date:  2008-03       Impact factor: 7.124

Review 10.  Omega-3 fatty acids. Current status in cardiovascular medicine.

Authors:  E B Schmidt; J Dyerberg
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

View more
  10 in total

1.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

2.  An Observational Study of Smoflipid vs Intralipid on the Evolution of Intestinal Failure-Associated Liver Disease in Infants With Intestinal Failure.

Authors:  Christina Belza; John C Wales; Glenda Courtney-Martin; Nicole de Silva; Yaron Avitzur; Paul W Wales
Journal:  JPEN J Parenter Enteral Nutr       Date:  2019-08-25       Impact factor: 4.016

3.  [13C]Methionine breath test to assess intestinal failure-associated liver disease.

Authors:  Debora Duro; Shimae Fitzgibbons; Clarissa Valim; Chi-Fu Jeffrey Yang; David Zurakowski; Melanie Dolan; Lori Bechard; Yong Ming Yu; Christopher Duggan; Tom Jaksic
Journal:  Pediatr Res       Date:  2010-10       Impact factor: 3.756

Review 4.  Short bowel syndrome in children: current and potential therapies.

Authors:  Victor Uko; Kadakkal Radhakrishnan; Naim Alkhouri
Journal:  Paediatr Drugs       Date:  2012-06-01       Impact factor: 3.022

Review 5.  Innovative parenteral and enteral nutrition therapy for intestinal failure.

Authors:  Hau D Le; Erica M Fallon; Vincent E de Meijer; Alpin D Malkan; Mark Puder; Kathleen M Gura
Journal:  Semin Pediatr Surg       Date:  2010-02       Impact factor: 2.754

6.  Evaluation of Emulsifying Ability of Phospholipids by Langmuir Monolayers and Stability of High Oil Ratio O/W Emulsions.

Authors:  Shanghui Li; Bing Zhang; Minsi Chang; Ruirong Zhang; Bei Liu; Tian Yin; Yu Zhang; Haibing He; Jingxin Gou; Yanjiao Wang; Xing Tang
Journal:  AAPS PharmSciTech       Date:  2022-07-28       Impact factor: 4.026

7.  Pediatric intestinal failure-associated liver disease is reversed with 6 months of intravenous fish oil.

Authors:  Kara L Calkins; James C Y Dunn; Stephen B Shew; Laurie Reyen; Douglas G Farmer; Sherin U Devaskar; Robert S Venick
Journal:  JPEN J Parenter Enteral Nutr       Date:  2013-07-26       Impact factor: 4.016

8.  Depletion and enrichment of phytosterols in soybean oil lipid emulsions directly associate with serum markers of cholestasis in preterm parenteral nutrition-fed pigs.

Authors:  Greg Guthrie; Barbara Stoll; Shaji Chacko; Mahmoud Mohammad; Candace Style; Mariatu Verla; Oluyinka Olutoye; Deborah Schady; Charlotte Lauridsen; Nick Tataryn; Douglas Burrin
Journal:  JPEN J Parenter Enteral Nutr       Date:  2021-04-30       Impact factor: 4.016

9.  Effect of Fermented Cottonseed Meal on the Lipid-Related Indices and Serum Metabolic Profiles in Broiler Chickens.

Authors:  Jun-Li Niu; Jun Zhang; Lian-Qing Wei; Wen-Ju Zhang; Cun-Xi Nie
Journal:  Animals (Basel)       Date:  2019-11-07       Impact factor: 2.752

10.  Use of Fish Oil-Based Lipid Emulsions in Infants With Intestinal Failure-Associated Liver Disease: A Case Series.

Authors:  David E St-Jules; Corilee A Watters; Lynn M Iwamoto
Journal:  Infant Child Adolesc Nutr       Date:  2014-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.